Insights

  • Date

  • Content Type

  • Reset

Article

The how, why and when of comparability exercises for ATMPs

16.05.22

By Elena Trude

Process changes are an inevitable part of most drug development programs, and this is particularly
Read More

Blog

Getting the balance right with biosimilars

16.05.22

By Peter Lavrencic

As many of the top-selling biotech drugs face loss of patent in the next few years, a large number...
Read More

Blog

A Meeting of Minds: Cell & Gene Conference Brings Tight-Knit Community Together

16.05.22

By Emma Cheesman-Ungstrup | Liron Sarid-Krebs | Elena Meurer

After two years stuck at home and only able to attend virtual conferences, the 2022 Cell & Gene Meeting...
Read More

Blog

The dos and don’ts of scientific due diligence

12.04.22

By Dr. Diane Seimetz

Partnering, mergers and acquisitions, and product licensing require careful preparation, particularly when it comes to
Read More

Article

Addressing the unique regulatory challenges of gene therapies

11.04.22

By Francesco Lanucara

Gene therapies have the potential to transform the treatment of disease by correcting an underlying
Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more